Our censored journals

Mens Sana Monographs

Volumn 6, Issue 1, 2008, Pages 244-256

  Healy, David ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Data access; Fundamental attributional eerror; Ghostwriting; Legal suits

Indexed keywords

EID: 44249114133     PISSN: 09731229     EISSN: 19984014     Source Type: Journal    
DOI: 10.4103/0973-1229.39302     Document Type: Article

References (21)

1. Beasley C.M., Dornseif B.E., Bosomworth J.C., Sayler M.E., Rampey A.H., Heiligenstein J.H., Thompson V.I., Murphy D.J., Massica D.N., (1991), Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression, BMJ, 303, p685-692.
2. Benbow A., (2004), Depressing misrepresentation, Lancet, 363, p1732-1733.
3. De Angelis C., (2006), The Influence of Money on Medical Science, JAMA, 296, p996-998.
4. th 2007. http://news.bbc.co.uk/1/hi/programmes/panorama/6317137.stm.
5. Editorial, (2004), Depressing research, Lancet, 363, p1335.
6. Elliott C., Chambers T., (2004), Introduction. In: Prozac as a Way of Life (C. Elliott and T Chambers eds.). University of North Carolina Press, Chapel Hill, p1-18,
7. Healy D., (1999a), Guest Editorial: A Failure to Warn, International Journal of Risk and Safety in Medicine, 12, p151-156.
8. Healy D., (1999b), Clinical trials and legal jeopardy, Bulletin of Medical Ethics, 153, p13-18.
9. Healy D., (2000a), Antidepressant induced suicidality, Primary Care Psychiatry, 6, p23-28.
10. Healy D., (2000b), Good Science or Good Business? Hastings Center Report, 30, p19-23.
11. Healy D., Cattell D., (2003), The Interface between authorship, industry and science in the domain of therapeutics, British J Psychiatry, 182, p22-27.
12. Healy D., (2004), Let Them Eat Prozac. New York University Press, New York. (The full correspondence is available on www.healyprozac.com).
13. Healy D., (2006a), Did regulators fail over selective serotonin reuptake inhibitors? BMJ, 333, p92-95.
14. Healy D., (2006b), Manufacturing Consensus, Culture, Medicine and Psychiatry, 30, p135-156.
15. Jick H., Kaye J.A., Jick S.S., (2004), Antidepressants and the risk of suicidal behaviors, JAMA, 292, p338-343.
16. Kahneman D., Slovic P., Tversky A., (1982), Judgement under Uncertainty. Cambridge University Press, Cambridge.
17. Keller M.D., Ryan N.D., Strober M., Klein R.G., Kutcher S.P., Birmaher B., Hagino O R., Koplewicz H., Carlsson G.A., Clarke G.N., Emslie G.J., Feinberg D., Geller B., Kusumakar V., Papatheodorou G., Sack W.H., Sweeney M., Wagner K.D., Weller E., Winters N.C., Oakes R., McCafferty J.P., (2001), Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial, J Am Acad Child Adolesc Psychiatry, 40, p762-772.
18. McHenry L., (2007), MSM Book Review. In: The Academia-Industry Symposium MSM 2007: Medical Practice and the Pharmaceutical Industry. And Ever the Duo Shall Meet (A.R. singh and S.A. Singh eds.), MSM, 5, Jan - Dec 2007, p228-232.
19. Oswald I., (1991), Letter, BMJ, 303, p1058.
20. Ryder S., (2004), Letter to Robert J Temple, Director, Office of Drug Evaluations, July 26, 2004. Available at: www.FDA.gov/ohms/dockets/ac/04/ briefing/2004-406561-31-pfizer-letter.pdf. p24-25. (Accessed 21 Sept 2007).
21. th November, p1. Available at: http://www.thes.co.uk/ search/story.aspx?story_id=2026283 (Accessed 21 Sept 2007).